Ricardo E. Perez

1.3k total citations
42 papers, 960 citations indexed

About

Ricardo E. Perez is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ricardo E. Perez has authored 42 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 28 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ricardo E. Perez's work include Cancer-related Molecular Pathways (14 papers), Ubiquitin and proteasome pathways (7 papers) and Epigenetics and DNA Methylation (6 papers). Ricardo E. Perez is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Ubiquitin and proteasome pathways (7 papers) and Epigenetics and DNA Methylation (6 papers). Ricardo E. Perez collaborates with scholars based in United States, Canada and China. Ricardo E. Perez's co-authors include Carl G. Maki, Lei Duan, Leonidas C. Platanias, Candice Mazewski, Eleanor N. Fish, Angels Navarro, Ikechukwu I. Ekekezie, Sherry M. Mabry, Chad D. Knights and Maria Laura Avantaggiati and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Ricardo E. Perez

40 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ricardo E. Perez United States 16 602 375 168 137 107 42 960
Gilles Doumont Belgium 13 531 0.9× 349 0.9× 147 0.9× 132 1.0× 48 0.4× 24 825
Sandeep Nambiar Germany 14 674 1.1× 344 0.9× 218 1.3× 121 0.9× 92 0.9× 26 948
Shi-Juan Mai China 16 690 1.1× 242 0.6× 306 1.8× 90 0.7× 79 0.7× 19 981
Marco Cirò Italy 10 859 1.4× 320 0.9× 225 1.3× 83 0.6× 98 0.9× 11 1.1k
Xiaochun Ni China 22 462 0.8× 385 1.0× 180 1.1× 152 1.1× 156 1.5× 42 1.1k
Xiong Jin South Korea 20 630 1.0× 299 0.8× 275 1.6× 148 1.1× 43 0.4× 42 1.1k
Lunxi Liang China 10 503 0.8× 457 1.2× 267 1.6× 299 2.2× 91 0.9× 16 1.0k
Jessica McCready United States 10 541 0.9× 251 0.7× 241 1.4× 143 1.0× 89 0.8× 12 831
Antony Letai United States 11 545 0.9× 303 0.8× 163 1.0× 104 0.8× 94 0.9× 11 840
Makiko Kawaguchi Japan 22 559 0.9× 312 0.8× 195 1.2× 318 2.3× 122 1.1× 72 1.3k

Countries citing papers authored by Ricardo E. Perez

Since Specialization
Citations

This map shows the geographic impact of Ricardo E. Perez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo E. Perez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo E. Perez more than expected).

Fields of papers citing papers by Ricardo E. Perez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo E. Perez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo E. Perez. The network helps show where Ricardo E. Perez may publish in the future.

Co-authorship network of co-authors of Ricardo E. Perez

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo E. Perez. A scholar is included among the top collaborators of Ricardo E. Perez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo E. Perez. Ricardo E. Perez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perez, Ricardo E., Elspeth M. Beauchamp, Mariafausta Fischietti, et al.. (2024). Targeting SLFN11-regulated pathways restores chemotherapy sensitivity in AML. PubMed. 1(4). 100037–100037.
2.
Perez, Ricardo E., Frank Eckerdt, & Leonidas C. Platanias. (2024). Schlafens: Emerging Therapeutic Targets. Cancers. 16(10). 1805–1805. 3 indexed citations
3.
Saleiro, Diana, Ewa M. Kościuczuk, Mariafausta Fischietti, et al.. (2023). Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells. Cancer Research Communications. 3(5). 943–951. 3 indexed citations
4.
Fischietti, Mariafausta, Frank Eckerdt, Ricardo E. Perez, et al.. (2022). SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression. Cancer Research Communications. 2(9). 966–978. 8 indexed citations
5.
Perez, Ricardo E., Diana Saleiro, Gary E. Schiltz, et al.. (2022). Regulation of IFNα-induced expression of the short ACE2 isoform by ULK1. Molecular Immunology. 147. 1–9. 1 indexed citations
6.
Duan, Lei, et al.. (2022). RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC. Scientific Reports. 12(1). 1049–1049. 13 indexed citations
7.
Fischietti, Mariafausta, Frank Eckerdt, Ahmet Arslan, et al.. (2021). Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma. Oncogene. 40(18). 3273–3286. 9 indexed citations
8.
Perez, Ricardo E., et al.. (2020). Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and in vivo tumor growth of triple-negative breast cancer. Cancer Biology & Therapy. 21(11). 1033–1040. 7 indexed citations
9.
Mazewski, Candice, Ricardo E. Perez, Eleanor N. Fish, & Leonidas C. Platanias. (2020). Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways. Frontiers in Immunology. 11. 606456–606456. 130 indexed citations
10.
Eckerdt, Frank, Jonathan B. Bell, Christopher Gonzalez, et al.. (2020). Combined PI3Kα-mTOR Targeting of Glioma Stem Cells. Scientific Reports. 10(1). 21873–21873. 33 indexed citations
11.
Mabry, Sherry M., Angels Navarro, Heather Menden, et al.. (2018). Lung epithelial-specific TRIP-1 overexpression maintains epithelial integrity during hyperoxia exposure. Physiological Reports. 6(5). e13585–e13585. 11 indexed citations
12.
Duan, Lei, Ricardo E. Perez, & Carl G. Maki. (2018). Alpha ketoglutarate levels, regulated by p53 and OGDH, determine autophagy and cell fate/apoptosis in response to Nutlin-3a. Cancer Biology & Therapy. 20(3). 252–260. 13 indexed citations
13.
Navarro, Angels, et al.. (2014). TRIP-1 via AKT modulation drives lung fibroblast/myofibroblast trans-differentiation. Respiratory Research. 15(1). 19–19. 11 indexed citations
14.
Duan, Lei, Guoguang Ying, Ricardo E. Perez, et al.. (2014). The Prolyl Peptidases PRCP/PREP Regulate IRS-1 Stability Critical for Rapamycin-induced Feedback Activation of PI3K and AKT. Journal of Biological Chemistry. 289(31). 21694–21705. 13 indexed citations
15.
Duan, Lei, Ricardo E. Perez, Michael Riis Hansen, Steven Gitelis, & Carl G. Maki. (2014). Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1. Cancer Biology & Therapy. 15(12). 1600–1612. 28 indexed citations
16.
Shen, Hong, et al.. (2013). Two 4N Cell-Cycle Arrests Contribute to Cisplatin-Resistance. PLoS ONE. 8(4). e59848–e59848. 25 indexed citations
17.
Perez, Ricardo E., Chad D. Knights, Jason Catania, et al.. (2010). Restoration of DNA‐binding and growth‐suppressive activity of mutant forms of p53 via a PCAF‐mediated acetylation pathway. Journal of Cellular Physiology. 225(2). 394–405. 32 indexed citations
18.
Perez, Ricardo E., et al.. (2009). Knockdown of ERp57 increases BiP/GRP78 induction and protects against hyperoxia and tunicamycin-induced apoptosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 297(1). L44–L51. 51 indexed citations
19.
Navarro, Angels, et al.. (2009). Higher TRIP-1 level explains diminished collagen contraction ability of fetal versus adult fibroblasts. American Journal of Physiology-Lung Cellular and Molecular Physiology. 296(6). L928–L935. 14 indexed citations
20.
Gavilondo, Jorge, et al.. (1982). Effect of two antiproteinases on the growth of transplantable tumors and the proliferation of untransformed and transformed cells in culture.. PubMed. 29(3). 315–22. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gilles Doumont Breakdown of academic impact, for papers by Sandeep Nambiar Breakdown of academic impact, for papers by Shi-Juan Mai Breakdown of academic impact, for papers by Marco Cirò Breakdown of academic impact, for papers by Xiaochun Ni Breakdown of academic impact, for papers by Xiong Jin Breakdown of academic impact, for papers by Lunxi Liang Breakdown of academic impact, for papers by Jessica McCready Breakdown of academic impact, for papers by Antony Letai Breakdown of academic impact, for papers by Makiko Kawaguchi
Rankless by CCL
2026